Month: June 2020

SAN DIEGO, June 30, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that it has completed its acquisition of CPI ASC Signal Division Inc. (ASC) from Communications & Power Industries LLC (CPI) following the receipt of regulatory approval from all required government authorities and completion of other closing items.The acquisition broadens Kratos’ space ground systems business with the addition of market-leading earth station antennas that are an important part of government strategic and tactical communications, especially for defense and intelligence operations, and are also used widely in the commercial world. ASC products also include radar antennas for air traffic control and weather applications, as well as High-Frequency...

Tom Higbie, a member of the Board of Directors of Team Tankers International Ltd. (the “Company”) has resigned as Director of the Company with effect from today. Mr. Scott Martin has, in accordance with the Company’s bye-laws, been appointed as a Director of the Company with effect from today, as Tom Higbie’s successor. Mr. Scott Martin is a Partner and Portfolio Manager at Solus Alternative Asset Management LP.  Mr. Martin joined Solus in 2012.  He previously Co-Headed Deutsche Bank’s Distressed Products Group in the Americas and has more than 24 years of financial industry experience in the high yield and distressed credit markets. Mr. Martin has a BS in Finance from the University of Virginia and an MBA from Columbia University. The Board of Directors wishes to thank Tom Higbie for his significant contribution...

TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has submitted today its Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“U.S. FDA”) for a Phase 3 confirmatory study for Bucillamine as a potential treatment in COVID-19.  Once the U.S. FDA allows the IND to go into effect, Revive will initiate a randomized, double-blind, placebo-controlled study of Bucillamine in patients with mild-moderate COVID-19 in Q3-2020.“We are very pleased in achieving this major milestone of filing our IND for a Phase 3 confirmatory study to evaluate Bucillamine in the treatment of patients with mild-moderate...

MONTREAL, June 30, 2020 (GLOBE NEWSWIRE) — Management of SIRIOS RESOURCES INC. (TSX VENTURE: SOI) is pleased to announce the completion of a non-brokered private placement for a total amount of $960,000. This amount was raised by issuing 6,400,000 flow-through shares at $0.15 per share. Sirios will use the proceeds of the private placement for exploration fieldwork that qualifies as Canadian exploration expenditures.Finder’s fees of $42,000 were paid. There will be a hold period of four months and one day on all securities issued under this financing. Two directors of Sirios participated in the financing for a total amount of $30,000. The TSX Venture Exchange has conditionally approved the private placement.About SiriosPioneer in the discovery of significant gold deposits in the Eeyou Istchee James Bay region of Quebec, Canada....

MONTRÉAL, 30 juin 2020 (GLOBE NEWSWIRE) — Les dirigeants de SIRIOS (TSX-V : SOI) ont le plaisir d’annoncer qu’ils ont procédé aujourd’hui à la clôture d’un placement privé sans l’entremise de courtier pour un montant total de 960 000$. Ce montant a été récolté par l’émission de 6 400 000 actions accréditives à 0,15$. Le produit du placement sera utilisé pour réaliser des travaux d’exploration sur les projets de la compagnie, qui se qualifient comme dépenses d’exploration au Canada.

VANCOUVER, British Columbia, June 30, 2020 (GLOBE NEWSWIRE) — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (PKG:CSE) (FSE:PT0) (OTC:PTNYF) is pleased to announce that it has completed a non-brokered private placement (the “Offering”) pursuant to which it issued an unsecured convertible note with a face value of US$210,000 to an arm’s length investor (the “Note”). The terms of the Note include the following:the sum of US$200,000 (the “Consideration”) was advanced to the Company on closing, and $10,000 (the “Initial Original Issue Discount”) was retained by the Noteholder through an original issue discount (the “OID”) for expenses related to the Offering, and the issuance of 300,000 common shares as investment incentive shares;the Note bears interest at a one-time guaranteed rate of 5% on the principal sum of each...

Pim Vervaat appointed CEO of Constantia FlexiblesConstantia Flexibles (“Constantia” or the “Company”) is pleased to announce today the appointment of Pim Vervaat as CEO of the Company, starting July 1st 2020.He will succeed Alexander Baumgartner who has over the last 5 years refocused Constantia on its core flexible packaging business, strengthened its positions in key markets and developed highly innovative solutions such as EcoLam providing sustainable and recyclable packaging with maximum functionalities ensuring consumers safety.Pim Vervaat joins Constantia Flexibles after a successful career at RPC Group Plc, which he joined in 2007 as CFO, led as CEO between 2013 and 2019 and turned into a global design and engineering business in plastic products (the largest market being packaging), quadrupling its sales to circa €4 billion.Josselin...

Nomination de Pim Vervaat en tant que CEOde Constantia Flexibles Constantia Flexibles annonce la nomination de Pim Vervaat en tant que CEO de la société à partir du 1er juillet 2020.Il succède à ce poste à Alexander Baumgartner qui, au cours des cinq dernières années, a recentré Constantia Flexibles sur le packaging flexible, son cœur de métier, renforcé ses positions sur ses marchés clés et développé des solutions de packaging innovantes, comme EcoLam qui concilie respect de l’environnement et recyclabilité avec toutes les propriétés techniques assurant la sécurité des consommateurs.Pim Vervaat rejoint Constantia Flexibles après une carrière réussie au sein de RPC Group Plc qu’il avait rejoint en 2007 en tant que directeur financier et dont il a été CEO de 2013 à 2019. Pim Vervaat a fait de RPC Group Plc une entreprise d’envergure internationale...

Fourth U.S. FDA Approval for Ultragenyx in the Past Three Years – All for Rare Diseases which Previously Had No Approved TherapiesUltragenyx to Host Conference Call Today at 4:00 pm Eastern TimeNOVATO, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Dojolvi™ (triheptanoin) as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). LC-FAOD are a group of rare, lifelong and life-threatening genetic disorders in which the body is unable to convert long-chain fatty acids into energy....